Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis

BACKGROUND: Blood-based amyloid biomarkers may provide a non-invasive, cost-effective and scalable manner for detecting cerebral amyloidosis in early disease stages. METHODS: In this prospective cross-sectional study, we quantified plasma Aβ(1–42)/Aβ(1–40) ratios with both routinely available ELISAs...

Descripción completa

Detalles Bibliográficos
Autores principales: De Meyer, Steffi, Schaeverbeke, Jolien M., Verberk, Inge M. W., Gille, Benjamin, De Schaepdryver, Maxim, Luckett, Emma S., Gabel, Silvy, Bruffaerts, Rose, Mauroo, Kimberley, Thijssen, Elisabeth H., Stoops, Erik, Vanderstichele, Hugo M., Teunissen, Charlotte E., Vandenberghe, Rik, Poesen, Koen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719262/
https://www.ncbi.nlm.nih.gov/pubmed/33278904
http://dx.doi.org/10.1186/s13195-020-00728-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719262/
https://www.ncbi.nlm.nih.gov/pubmed/33278904
http://dx.doi.org/10.1186/s13195-020-00728-w

Ejemplares similares